C2-8 (Synonyms: Polyglutamine Aggregation Inhibitor III) |
カタログ番号GC43079 |
C2-8は、ポリグルタミン(polyQ)凝集の阻害剤です(再生可能なHDQ51およびPC12細胞に対するIC50はそれぞれ25および0.05μM)。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 300670-16-0
Sample solution is provided at 25 µL, 10mM.
C2-8 is an inhibitor of polyglutamine (polyQ) aggregation (IC50s = 25 and 0.05 μM for recombinant HDQ51 and in PC12 cells, respectively). It also inhibits polyQ aggregation in organotypic hippocampal slice cultures isolated from R6/2 transgenic mice and reduces neurodegeneration in a dose-dependent manner in a Drosophila model of Huntington's disease. C2-8 (100 and 200 mg/kg) reduces huntingtin aggregate size, reduces neuronal atrophy, and improves motor performance in a rotarod test in the R6/2 transgenic mouse model of Huntington's disease.
Average Rating: 5
(Based on Reviews and 35 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *